Overweight

152 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Overweight
Treatment and conditionWhere it standsTrials
Agbs for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Apitegromab for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
arabinoxylan for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
ATR-258 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Autoinjector + Maridebart Cafraglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
AZD6234 for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Barley beta-glucan(3.0g) for overweightTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Berobenatide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Beta-glucan addition to a restricted calorie of meal replacements and carbohydrate diet. for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BI 1820237 for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
BI 1820237 + Placebo for BI 1820237 + Placebo for BI 456906 + Survodutide for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
BI 3034701 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bimagrumab for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for obesity, abdominalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cagrilintide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Cagrilintide and Semaglutide + Placebo for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CagriSema for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
CagriSema (Cagrilintide B + semaglutide I) for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CagriSema (Cagrilintide B + semaglutide I) + Low Energy Diet for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Calorie restriction via total food replacement for obesity, morbidTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ci + ends for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CI + No ENDS for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Comprehensive weight loss + Enhanced lifestyle changes + Naltrexone-Bupropion + Phentermine-Topiramate for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Comprehensive weight loss + Enhanced lifestyle changes + Semaglutide + Tirzepatide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Continous Glucose Monitor (CGM) + Low-calorie diet + Personalized exercise program for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Counseling + Phone calls + Self-monitoring tools + Text Messages for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cryolipolysis for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
cryolipolysis and aerobic exercise for obesity, abdominalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cryolipolysis device for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Culturally Tailored Diabetes Prevention Program for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Culturally Tailored Diabetes Prevention Program + Culturally Tailored DPP Enhanced with Socioeconomic Supports for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Danuglipron for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin plus Glucophage (MET ER) for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ecnoglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)8
Elecoglipron for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Electronic Cigarettes (EC) for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Eloralintide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)13
Eloralintide + Macupatide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Eloralintide + Tirzepatide for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
eloralintide and tirzepatide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Empagliflozin for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ends + ni for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
EQW plus DAPA for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Exenatide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Food-based diet for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Formula diet for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Formulation A + Formulation B6 for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
GnRH antagonist + Letrozole for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Green coffee + beta-glucan for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Green coffee extract for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + naltrexone and bupropion (combination) for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + Phentermine-Topiramate for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Group Therapy Program + Semaglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
gut-brain axis (GLP-1)-activating food carbohydrate for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HRS9531 for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
HRS9531 Injection for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
HRS9531 injection;Placebo for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
IN-B00009 for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intensive lifestyle Intervention + Meal replacement system for obesityTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Intraoral Negative Pressure Therapy + Oral Appliances + Positional Therapy + Surgery + Tongue Muscle Strength Training for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
K-757 120 mg BID and K-833 100 mg BID for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
K-757 120 mg BID and matching placebo to K-833 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
K-757 and K-833 for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
K-757 and K-833 BID + K-757 and K-833 QD for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Liraglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Liver-expressed antimicrobial peptide 2 for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
low calorie diet + Phentermine/topiramate for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Macupatide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Maridebart Cafraglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Maridebart Cafraglutide for overweightPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching placebo to K-757 and matching placebo to K-833 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo-Garetosmab + Matching Placebo-Trevogrumab + Semaglutide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo-Garetosmab + Matching Placebo-Trevogrumab + Semaglutide + TREVOGRUMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo-Garetosmab + Semaglutide + TREVOGRUMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo-Trevogrumab + Semaglutide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo-Trevogrumab + Semaglutide + TREVOGRUMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo-Trevogrumab + Semaglutide + TREVOGRUMAB + GARETOSMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mazdutide for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Meal Replacement Therapy for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MET097 for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
MKP10241 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NI + No ENDS for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nicotine replacement therapy (NRT) for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
NNC0487-0111 for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Oral BGE-102 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)16
Oxytocin for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)5
Oxytocin for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pemvidutide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Petrelintide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PF-06882961 (Cohort 3) for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PF-06882961 (Cohorts 1 and 2) for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PF-08653944 for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine / Topiramate Oral Product for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine-Topiramate for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine-Topiramate ER for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Photobiomodulation for obesity, morbidPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo (matched to semaglutide) + Zenagamtide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Eloralintide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Eloralintide + Macupatide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Eloralintide + Tirzepatide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + MAZDUTIDE for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Naperiglipron for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Oxytocin for obesityTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Reduced-calorie diet + Tirzepatide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Standardized diet and physical activity counseling throughout the study. + Retatrutide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo Nasal Spray for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
placebo with matching dosage + ECNOGLUTIDE for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Qsymia for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Qsymia 11.25Mg-69Mg Extended Release Capsule + Qsymia 15Mg-92Mg Extended Release Capsule + Qsymia 3.75Mg-23Mg Extended Release Capsule + Qsymia 7.5Mg-46Mg Extended Release Capsule for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Qsymia and lifestyle management therapy for pediatric obesityTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
RAY1225 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
responsive neurostimulation for obesity, morbidTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)12
Ribupatide for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)20
Semaglutide for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide + BIMAGRUMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide + Cagrilintide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Semaglutide + TREVOGRUMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide + TREVOGRUMAB + GARETOSMAB for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Structured weight-loss program for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Survodutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)15
Time-restricted eating for overweightTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)23
Total Diet Replacement for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Total Diet Replacement (TDR) Program for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Trevogrumab for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBT251 for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
UBT251 Injection 2.0 mg and UBT251 Injection Placebo for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBT251 Injection 4.0 mg for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBT251 Injection 4.0 mg (ID 0.5 mg) and UBT251 Injection Placebo for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBT251 Injection 4.0 mg (ID 1.0 mg) and UBT251 Injection Placebo for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBT251 Injection 6.0 mg for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
UBT251 Injection 6.0 mg and UBT251 Injection Placebo for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ultrasound lipolysis for obesity, abdominalTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 for obesity, morbidTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 Mid Dose for pediatric obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 oral capsule for pediatric obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VI-0521 Top Dose for pediatric obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Virtual Weight Management Coaching + Semaglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
WVE-007 for obesityPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zeltiq CoolSculpting device for obesityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1